ResMed Inc
I · AI Analysis
The brief
ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).
ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance] [Sentinellis calculation].
ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.
Sentinellis health
10/10
Financially healthy
Market capitalisation
$30.1B
Revenue (TTM)
$5.1B
Explainers
How we read these numbers
Plain-English guides · no account needed
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
ReadPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
ReadAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
ReadII · Recent news
What moved
3 stories · ranked by relevance
- Macro2026-05-20
ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access
Simply Wall St
- Macro2026-05-19
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Yahoo Finance
- Macro2026-05-19
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
Yahoo Finance
Premium · Free with any account
The stock has declined nearly 20% over the past three months despite strong fundamentals, indicating investors may be concerned about growth sustainability or competitive pressures not yet visible in the financial data [Simply Wall St].
Risks
4
Opportunities
4
Red flags
1
Leadership
10
8 more findings in the full report — free with any account.
Unlock the full ResMed Inc analysis
Create a free account to access the complete AI-generated report with inline citations.
- 4 risks, 4 opportunities and 1 red flag — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare — or comparable health
Want this for your watchlist?